Search Results for: FORMULATION DEVELOPMENT TECHNOLOGY A Novel
Articles
December 5, 2025
Mikart, LLC
Mikart, LLC 3100 Cumberland Blvd SE, Ste. 1000 Atlanta, GA 30339 W: http://www.mikart.com COMPANY DESCRIPTION Mikart’s 45+ years of experience...
December 5, 2025
Serán Bioscience
Serán Bioscience, LLC 63047 Layton Ave. Bend, OR 97701 T: (541) 797-2148 E: Hello@seranbio.com W: seranbio.com LinkedIn: https://www.linkedin.com/company/seran-bioscience/ ...
December 5, 2025
Adare Pharma Solutions
Adare Pharma Solutions 7722 Dungan Road Philadelphia, PA 19111 Email: BusDev@adareps.com AdarePharmaSolutions.com COMPANY DESCRIPTION Adare Pharma Solutions is a global...
December 5, 2025
H&T Presspart
H&T Presspart E: blackburn@presspart.com W: www.presspart.com H&T Presspart is a market leading developer and manufacturer of drug delivery devices...
November 25, 2025
Bracco, Limula & University of Fribourg Join Forces to Improve Cell & Gene Therapy Manufacturing
Bracco Imaging and Limula recently announced the launch of a research and development (R&D) project in collaboration with Prof. Nicola...
November 17, 2025
Acumen Pharmaceuticals Announces First Participant Dosed in Phase 2 Open-Label Extension Study of Sabirnetug in People With Early Alzheimer’s Disease
Acumen Pharmaceuticals, Inc. recently announced the first participant has been dosed in the open-label extension (OLE) portion of its Phase...
November 13, 2025
WHITEPAPER - Advancements in Intradermal Delivery: From Historic Techniques to Modern Innovations
This white paper explores the evolution of intradermal delivery methods, comparing historic methods of delivery such as the Mantoux technique with modern innovations such as the Terumo Immucise™ Intradermal Injection System.
October 9, 2025
Ligand Partner SQ Innovation Receives FDA Approval for Lasix ONYU, an At-Home Treatment for Edema in Heart Failure Patients
Ligand Pharmaceuticals Incorporated recently announced that its partner SQ Innovation Inc. has received approval from the US FDA for Lasix...
October 7, 2025
SPECIAL FEATURE - Excipients: Innovation in a Shifting Pharma Landscape
Cindy H. Dubin speaks with several companies and highlights this innovation and reveals how excipient suppliers are doing their part to ensure a reliable, resilient, and compliance-driven supply chain.
September 26, 2025
Harrow to Acquire Melt Pharmaceuticals
Harrow recently announced it has entered into an agreement to acquire Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company pioneering non-opioid,...
